机译:开发新型抗癫痫药:在癫痫模型中表征具有全身活性的甘丙肽类似物NAX 5055
Department of Pharmacology and Toxicology College of Pharmacy University of Utah 84108 Salt Lake City Utah;
Department of Medicinal Chemistry College of Pharmacy University of Utah 84108 Salt Lake City Utah;
NeuroAdjuvants Inc. 84108 Salt Lake City Utah;
Department of Pharmacology and Toxicology College of Pharmacy University of Utah 84108 Salt Lake City Utah;
Department of Pharmacology and Toxicology College of Pharmacy University of Utah 84108 Salt Lake City Utah;
Department of Medicinal Chemistry College of Pharmacy University of Utah 84108 Salt Lake City Utah;
Department of Medicinal Chemistry College of Pharmacy University of Utah 84108 Salt Lake City Utah;
Department of Medicinal Chemistry College of Pharmacy University of Utah 84108 Salt Lake City Utah;
Neuropeptide; anticonvulsant drug; audiogenic seizures; 6 Hz seizure; corneal kindled mouse;
机译:甘丙肽类似物NAX 5055在有症状的小儿痉挛多发大鼠模型中的功效和耐受性
机译:甘丹素模拟NAX 5055在症状性婴儿痉挛多次大鼠模型中的疗效和耐受性
机译:新型抗癫痫药物候选药物的药理概况PACSEVONIL:啮齿动物癫痫发作和癫痫模型的表征
机译:新生儿癫痫中的抗癫痫药物治疗策略
机译:NAX-5055的性质:一种新型的系统可用的基于甘丙肽的神经肽。
机译:开发新型抗癫痫药:在癫痫模型中表征具有全身活性的甘丙肽类似物NAX 5055
机译:开发新型抗癫痫药物:NAX 5055的表征,一种系统性活性的甘醇模拟,癫痫模型